In addition to a continued focus on growing drug pipelines, and the increasing use of artificial intelligence (AI) and data ...

The presentation suggests ways to educate patients on the options available to them, with the hope of ultimately improving ...

Titled “State of the Industry—The Evolving Landscape of Healthcare Coverage and Access in 2025,” 1 the goal of the Access USA ...

The session provides an overview of the uninsured population, and also tackles challenges faced by patients when it comes to ...

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, ...

A roundtable explores how patient access needs are being measured, while also discussing the value of affordability in ...

The conference’s first panel offers insight on the current state of awareness among beneficiaries of the Part D cap and ...

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life sciences co-leader, outlines the ways that tariffs disrupt pharma supply ...

Jen Butler, chief commercial officer, Pleio, discusses how personalization, connectivity, technology, and proactive support ...

The move by the CDMO—who also houses a North American HQ in Indiana—expresses its interest in providing compliant storage and ...

Jonathan James, CEO, Hope Charities, discusses how, despite policy advancements, millions of people still face barriers to ...

1. AstraZeneca to invest $2.5 billion in new global strategic R&D centre, biotech agreements and manufacturing in Beijing.